A detailed history of Quent Capital, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Quent Capital, LLC holds 1,202 shares of ADPT stock, worth $7,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,202
Previous 1,202 -0.0%
Holding current value
$7,680
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$2.88 - $4.8 $2,545 - $4,243
884 Added 277.99%
1,202 $3,000
Q1 2023

Jun 14, 2024

SELL
$7.8 - $10.11 $6,895 - $8,937
-884 Reduced 73.54%
318 $2,000
Q4 2022

Jan 19, 2023

BUY
$6.26 - $9.34 $444 - $663
71 Added 28.74%
318 $0
Q3 2022

Nov 10, 2022

BUY
$6.5 - $12.67 $1,605 - $3,129
247 New
247 $2,000
Q2 2022

Aug 08, 2022

SELL
$6.4 - $14.73 $1,235 - $2,842
-193 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$10.12 - $28.9 $1,953 - $5,577
193 New
193 $3,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.